Latest From Ansell Ltd.
It was a busy summer for Chinese pharmaceutical companies and investors who went global shopping, eying mega acquisition deals since China announced plans to accept overseas clinical trial data and global multicenter studies as part of its policies.
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.
Noteworthy news from medtech start-ups. This month we profile Silere Medical, which is developing neurostimulation technology to suppress tinnitus, OrthoData, which makes an implantable diagnostic device to monitor spinal fusion, and ProTip, which is developing porous titanium devices for ear, nose and throat applications.
Cyberkinetics is developing an implantable brain-machine interface initially aimed at helping paralyzed patients communicate through a computer that they control mentally. Ultimately, the firm views its BMI technology as a platform applicable to treating a wide range of neurological disorders.
- Consumables, Central Supplies
- Infection Control-Sterilization
- Therapeutic Areas
- Pacific Dunlop Ltd.
- Parent & Subsidiaries
- Ansell Ltd.
- Senior Management
Doug Tough, Managing Dir. & CEO
Rustom Jilla, SVP, CFO
- Contact Info
Phone: (61) 3 9270 7270
3/678 Victoria Street
Richmond, Vic. 3121., 3150
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.